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Bovine spongiformencephalopathy (BSE)prionswere responsible for anunforeseen epizootic in cattlewhichhadavast social, economic,
and public health impact. This was primarily because BSE prions were found to be transmissible to humans. Other species were also
susceptible toBSEeither bynatural infection (e.g., felids, caprids) or in experimental settings (e.g., sheep,mice).However, certain species
closely related to humans, such as canids and leporids, were apparently resistant to BSE. In vitro prion amplification techniques (saP-
MCA)were used to successfullymisfold the cellular prionprotein (PrPc) of these allegedly resistant species into aBSE-typeprionprotein.
The biochemical and biological properties of the new prions generated in vitro after seeding rabbit and dog brain homogenates with
classical BSEwere studied. Pathobiological features of the resultant prion strainswere determined after their inoculation into transgenic
mice expressingbovine andhumanPrPC. Strain characteristics of the in vitro-adapted rabbit anddogBSEagent remained invariablewith
respect to the original cattle BSE prion, suggesting that the naturally low susceptibility of rabbits and dogs to prion infections should not
alter their zoonotic potential if these animals became infected with BSE. This study provides a sound basis for risk assessment regarding
prion diseases in purportedly resistant species.
Introduction
Bovine spongiform encephalopathy (BSE) was first described in
cattle in 1985 (Wells et al., 1987) and became a major public
health concern when evidence linked it to variant Creutzfeldt-
Jakob disease in humans (Bruce et al., 1997; Hill et al., 1997).
Unlike other animal prion diseases, BSE has transmitted natu-
rally to humans and also to other domestic species including
goats (Eloit et al., 2005), cats (Aldhous, 1990; Wyatt et al., 1991),
zoological-kept felidae (Willoughby et al., 1992; Lezmi et al.,
2003; Bencsik et al., 2009; Eiden et al., 2010), and ruminants
(Kirkwood and Cunningham, 1994). Experimentally, sheep are
susceptible to BSE (Foster et al., 1993; Bellworthy et al., 2008) as
are many laboratory animals including primates, pigs, mice, and
guinea pigs (Fraser et al., 1988; Lasmezas et al., 1996; Wells et al.,
2003; Castilla et al., 2004; Konold et al., 2009; Safar et al., 2011).
Most BSE cases diagnosed in cattle have been classified as
classical BSE, which was believed to be caused by a single stable
agent (Wells and Wilesmith, 1995). BSE exhibits a unique bio-
chemical “signature”, which has solely been associated with this
particular prion strain, has been observed in the vast majority of
BSE cases in cattle and is maintained when transmitted to other
susceptible species (Collinge et al., 1996; Stack et al., 2002;
Biacabe et al., 2004).
Even though BSE has crossed many transmission barriers,
other species which have presumably been exposed to BSE prions
have not been documented to succumb to prion disease. Among
these are the members of the canidae and leporidae families
(Gibbs andGajdusek, 1973; Barlow and Rennie, 1976; Vorberg et
al., 2003). The lack of literature in these species with respect to
natural or experimental TSE transmissions supported their cate-
gorization as purportedly prion-resistant. However, recently de-
veloped in vitro prion amplification techniques, such as protein
misfolding cyclic amplification (PMCA) (Saborio et al., 2001)
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and its variants (Castilla et al., 2006), are allowing reclassification
of the strength of certain species transmission barriers
(Fernandez-Borges et al., 2009; Chianini et al., 2012). The normal
cellular prion protein (PrPC) from these purportedly resistant
species can be successfully misfolded in vitro. However, it is es-
sential to determine whether these novel abnormal prions are
capable of inducing disease and whether their strain properties
are maintained or not after passage through a supposedly resis-
tant species. Due to its ability to infect humans, prediction of the
behavior of BSE in purportedly resistant species that are either
consumed by or in close contact with humans is vital for risk
assessment. The design of experiments involving the natural,
long-lived hosts is frequently unaffordable. Therefore, the use of
repeated passages of intracerebral inoculation of transgenic
mouse models (overexpressing the PrPC of the species under
investigation) are used to overcome these limitations (Castilla et
al., 2004; Sigurdson et al., 2006). Furthermore, an in vitro ap-
proach in which brain homogenates from the chosen species un-
der investigation are submitted to several rounds of amplification
by PMCA greatly increases transmission efficiency (Castilla et al.,
2008; Chianini et al., 2012).
In this study, we analyzed the biochemical and biological
properties of new prions generated in vitro after seeding rabbit
and dog brain homogenates with classical BSE. Pathobiological
features of the resultant prion strains were studied after their
inoculation in transgenic mice expressing bovine and human
PrPC. Strain characteristics of the in vitro-adapted rabbit and dog
BSE agent remained invariable with respect to the original cattle
BSE prion, suggesting that the naturally low susceptibility of rab-
bits and apparently of dogs to prion infections (Polymenidou et
al., 2008; Kurt et al., 2011) should not alter their zoonotic poten-
tial if these animals became infected with BSE. This study pro-
vides a sound basis for risk assessment regarding prion diseases in
purportedly resistant species.
Materials andMethods
Inocula preparation for in vitro prion replication studies. Brain homoge-
nates (101 in PBS) for use as seedswere prepared bymanual potter from
a brain of a clinically affected BSE-positive bovid (TSE/08/59) supplied
by the Veterinary Laboratory Agency (NewHaw, Addlestone, Surrey, UK).
The titer of this inoculumwas108 ID50 units per gram of bovine brains-
tem, as determined in the boTg110mouse line (Castilla et al., 2003).
Generation of in vitro PrPres by serial automated PMCA. The in vitro
prion replication, including the PrPSc detection of amplified samples,
was performed as described previously with minor modifications (Saa´ et
al., 2006). Briefly, 5 l aliquots of 10%, and 50% in the case of the dog,
brain homogenate from animals infected by BSE were diluted in 50l of
10% normal rabbit and dog brain homogenates and loaded onto 0.2 ml
PCR tubes. Rabbit and dog brains used for substrate were previously
perfused using PBS  5 mM EDTA. The blood-depleted brains were
frozen immediately before preparing the 10% brain homogenates
(PBS  NaCl 1%  1% Triton X-100). Tubes were positioned on an
adaptor placed on the plate holder of a microsonicator (Misonix, Model
4000) and subjected to cycles of 30 min incubation at 38°C followed by a
20 s pulse of sonication at potency 80. Samples were incubated in the
water bath of the sonicator without shaking. Serial rounds of PMCA
consisted of 48 h of standard PMCA followed by serial in vitro 1:10
passages in fresh rabbit brain substrate. An equivalent number of unseeded
tubes containing the corresponding brain substrate were subjected to the
same number of rounds of serial automated PMCA (saPMCA) to control
cross-contamination and/or the generation of spontaneous PrPres. The de-
tailed protocol for PMCA, including reagents, solutions, and troubleshoot-
ing, were previously published (Saa´ et al., 2005).
Inocula preparation for in vivo prion replication studies. Inocula for
second passages where prepared by homogenizing the harvested CNS
(spinal cord and olfactory bulb)material from infected first passagemice
1:10 (w/v) with sterile PBS. The homogenates where filtered through a
surgical gauze. Homogenate fromonemouse brain from the first passage
was used to prepare the inocula, themice used had 365 d postinoculation
(dpi) in the case of BSE-DoPrPres and 312 in the case of BSE-RaPrP res.
Biochemical characterization of in vitro-generated and in vivo-generated
prion strains. The standard procedure to digest PrPSc was performed
following the basic conditions described previously (Castilla et al.,
2005a). Briefly, PMCA samples were digested using 85–200 g/ml pro-
tease K (PK) during 1 h at 42°C with shaking (450 rpm). Digestion was
stopped by adding electrophoresis loading buffer and the samples were
analyzed by Western blotting.
tgBov and tgHum mice inoculation. The bovine PRNP expression
mouse model boTg110 (tgBov) was established and characterized as de-
scribed previously (Castilla et al., 2003; Castilla et al., 2005b; Espinosa et
al., 2007). Briefly, these mice express bovine PrPC under the murine
PRNP promoter in a murine PrP0/0 background. Bovine PrPC expres-
sion levels in this mouse line are stated to be eightfold higher than the
PrPC levels found in cattle brain homogenates. As a model to assess the
theoretical human susceptibility, the model Tg340 (tgHum), which ex-
presses human PRNP (4-fold higher than in human brain) with a methi-
onine at codon 129 (Met129) also on a murine PRNP-null background,
was used (Padilla et al., 2011).
Each 6- to 8-week-oldmouse received an intracerebral inoculation (20
l) through the parietal bone using a 50 l SGC precision syringe, a 25
gauge needle, and a repeatability adaptor. During the inoculation proce-
dure, the mice were kept under deep gaseous anesthesia (isoflurane). A
subcutaneous dose of buprenorphine was administered before awaken-
ing to minimize postinoculation pain.
Mice were kept under controlled conditions at a room temperature of
21–22°C, 12 h light/dark cycle and 60% relative humidity. Cages were in
HEPA-filtered (both air inflow and extraction) ventilated racks. The
mice were fed ad libitum. To evaluate transmissible spongiform enceph-
alopathy (TSE)-related clinical signs, mice were observed daily and their
neurological status was assessed twice a week. The presence of three signs
of neurological dysfunction (using 10 different criteria) (Scott et al.,
1989) was necessary for a mouse to score positive for prion disease. Only
female mice were used to avoid male aggression.
In vitro inocula (BSE-RabPrPres and BSE-DogPrPres) were subjected
to at least 15 rounds of saPMCA (a 1015 dilution of the initial seed) after
the first evidence of in vitro crossing of the species barrier (Fig. 1).
The groups were designed as follows: for the boTg110 model 10 ani-
mals were inoculated with cattle BSE on first passage and 9 on second
passage; 16 animals were inoculated with BSE-RabPrPres on first passage
and 12 on second; 17 animals were inoculated with BSE-DogPrPres on
first passage and 13 on second, and finally, as a negative control 12 mice
where inoculated with brain homogenate from a clinically healthy, BSE-
negative cow. For theTg340 (Met129)model, 10 animals were inoculated
with cattle-BSE, 9 with BSE-RabPrPres, and 6 with BSE-DogPrPres.
Ethics statement. The procedures involving animals were approved by
the animal experimentation ethics committee of the Autonomous Uni-
versity of Barcelona (Reference No. 585-3487) in agreement with Article
28, sections (a), (b), (c), and (d) of the “Real Decreto 214/1997 de 30 de
Julio” and the EuropeanDirective 86/609/CEE and the European council
Guidelines included in the European Convention for the Protection
of Vertebrate Animals used for Experimental and Other Scientific
Purposes.
Sample processing and general procedures. Immediately after mice were
killed (by intraperitoneal overdose of pentobarbital and decapitation)
the brain was extracted and placed into 10% phosphate buffered forma-
lin. Transversal sections of the brain were obtained at the level of the
optic chiasm, piriform cortex, and medulla oblongata. Samples were
dehydrated through increasing alcohol concentrations and xylene before
embedding in paraffin wax. Four-micrometer sections were cut and
mountedonglassmicroscope slides and stainedwithhematoxylin and eosin
formorphological evaluation.Further slidesweremounted in3-trietoxysilil-
propilamine-coated glass slides for immunohistochemical studies.
Immunohistochemistry. Immunohistochemistry (IHC) against PrPd
was performed as previously described (Siso et al., 2004). Briefly, depar-
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affinized sections were immersed in formic acid and boiled at low pH in
a pressure cooker, with endogenous peroxidases blocked. After pretreat-
ment with PK, the sections were incubated overnight with primary
anti-PrP mAb 6H4 antibody (1:2000, kindly provided by Prionics AG),
and finally, visualized using the Dako EnVision system and 3,3-
diaminobenzidine as the chromogen substrate as per the manufacturer’s
instructions. As a background control, the primary antibody incubation
was omitted. No labeling was observed in any of the control slides.
Semiquantification and data analysis. Semiquantification of the histo-
pathological lesions and PrPd immunolabeling was performed. Subjec-
tive scores ranging from 0 (absence of spongiosis or immunolabeling) to
5 (maximum intensity of lesion or immunolabeling) were assigned to
each brain area studied and profiles were constructed. Intermediate lev-
els were (1) mild, (2) moderate, (3) marked, and (4) intense. Each area
was investigated as a global region for the score.
The brain profiling approach consisted of a systematic screening of the
different brain regions to obtain comparable data from the different
prions used to challengemice. A total of 15 different regions were chosen
and semiquantitatively evaluated by eye as a whole for labeling intensity.
The results were plotted on a graph that summarizes the distribution of
lesions and PrPd throughout the brain. This allowed for comparison of
the different groups studied.
For both parameters, results were plotted as a function of the anatom-
ical area. Areas were ordered along the x-axis in an attempt to represent
the caudorostral axis of the brain. This methodology was adapted from a
previous study performed on BSE-infected cattle (Vidal et al., 2005). For
statistical analysis, the Mann–Whitney U test for nonparametric vari-
ables was applied (*p  0.05 with 95% confidence interval, **p  0.01
with 99% confidence interval). Graphs were plotted using Microsoft
Office 2007 Excel software.
Results
In vitro generation of rabbit and dog adapted BSE prions
We seeded normal rabbit and dog brain homogenates in vitro
with cattle BSE brain homogenate before saPMCA in an attempt
to study the ability to generate rabbit and dog adapted BSE PrPres
(BSE-RaPrPres and BSE-DoPrPres, respectively). Although saP-
MCA is not a quantitative technique, rabbit PrPC appeared to be
more susceptible to protein misfolding as BSE-seeded rabbit
brain homogenate generated PK resistant RaPrPres by round 7
(Ferna´ndez-Borges et al., 2009; Chianini et al., 2012) compared
with dog PrPC which showed higher resistance (Fig. 1). This
impaired ability to convert dog PrPC was consistent in all the
seeds used (our unpublished observations) suggesting that in
vitro propagation was impeded. Because the in vitro crossing of
species barriers is a quasi-stochastic phenomenon, we modified
the settings of saPMCA in an attempt to adapt it to the potentially
most resistant species barrier known in mammals. Thus, dog
brain homogenates were seeded with a larger amount of BSE-
positive cattle brain material (50% instead of the standard 10%)
and the dilutions were performed at 1:2 (v/v) during subsequent
rounds of PMCA.These changes enabled the cattle-dog transmis-
sion barrier to be overcome at round 5 (Fig. 1). Biochemical
characterization, by Western blotting, of the in vitro generated
Figure 1. In vitro amplification experiments. Rounds (R1-R10) of serial automated PMCA using rabbit, dog, and cattle brain homogenate as substrate. Note dog brain inocula are at 10 and 50%.
Serial rounds (R5-R8 for rabbit and R3-R10 for dog) were selected to show biochemical analyses of BSE seeded PrP res generated in vitro by saPMCA. Samples from one of four tubes subjected to
saPMCA were digested with 100g/ml PK and analyzed by Western blot using monoclonal antibody D18. Control, Undigested cattle brain homogenate; R, round.
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BSE-DoPrPres showed a similar pattern compared with the cattle
BSE homogenate used as seed (Fig. 2). Once the species barriers
were initially overcome in vitro, the derived BSE-RaPrPres and
BSE-DoPrPres products were further amplified efficiently in vitro
(data not shown). We selected saPMCA products from BSE
seeded normal rabbit and dog brain homogenates and cattle
brain derived BSE to be used as challenge inocula. All samples
were subjected to at least 15 rounds of saPMCA (a 1015 dilution
of the initial seed which, according to its infectious titer, ensured
no residual infectivity was left) after the first evidence of in vitro
crossing of the species barrier.
Unaltered pathobiological BSE features after inoculation of
rabbit, dog, and cattle adapted BSE prions in a bovine
transgenic mouse model
To assess the infectivity of the newly in vitro generated prions,
transgenicmice overexpressing bovine PrPC (Castilla et al., 2003)
were challenged intracerebrally. Brain homogenate fromhealthy,
BSE-negative cattle was used as a negative control (Table 1).
A first passage through the transgenic mice of the cattle BSE
and BSE-RaPrPres or BSE-DoPrPres inocula resulted in strikingly
similar survival curves (Fig. 3) and no statistically significant dif-
ferences were observed between the three inocula. The approxi-
mate difference in survival times of 40 d postinoculation (Table
1) might be a consequence of a low titer of the BSE-RaPrPres and
BSE-DoPrPres samples amplified in vitro or because of a change
of the prion strain after overcoming the cattle-rabbit and cattle-
dog species barriers. A second passage through the transgenic
mice was then performed to address this question. Upon this
second passage, the incubation period of mice inoculated with
cattle BSEwas not statistically significantly different (p 0.9296,
Mann–Whitney test) to the first passage, whereas the other two
inocula showed a significant reduction of the incubation periods
compared with their respective first passages (p 0.006 for BSE-
RaPrPres and p  0.000,005 for BSE-DoPrPres, Mann–Whitney
test). This could be interpreted as host adaptation process or as an
increased titer compared with the in vitro generated inoculum.
This reduction was especially greater for the BSE-DoPrPres,
which was significantly shorter compared with the incubation
period of the second passage of cattle BSE inoculated mice (p
0.0003, Mann–Whitney test). Shorter survival times than the
original cattle BSE inocula have also been reported for sheep-
passaged BSE (Espinosa et al., 2007). On the other hand, second
passage BSE-RaPrPres showed no statistically significant differ-
ences in the incubation period compared with cattle BSE (p 
0.2207, Mann–Whitney test).
Brain homogenates from the sick mice were obtained and the
molecular weights and glycosylation patterns of PrPres after PK
digestion were studied by Western blotting. No differences were
observed between the PrPres of BSE infected cattle and the prions
recovered from inoculating tgBovmice with either cattle BSE and
rabbit or dog in vitro amplified prions. On second passage, the
biochemical profile also remained unaltered (Fig. 4).
We then examined microscopically the brains of the inocu-
lated mice. Consistent spongiform changes were observed in all
BSE inoculated animals consisting of variably sized vacuoles in
the neuropil of the gray matter (Fig. 5). The distribution of the
lesion intensity throughout the brain was assessed semiquantita-
tively and showed that the three inocula yielded a very similar
lesion profile on the first passage (data not shown). Lesions were
particularly intense in the medulla oblongata, cerebellar nuclei,
mesencephalon, thalamus, and striatum with significantly less
involvement of the neocortex, cerebellar cortex, and piriform
cortex. The hippocampal formation also showed some degree of
spongy change. The brain lesion profiles of the second passage-
inoculated animals remained unchanged compared with the first
passage and also between the different inocula (Fig. 5); no signif-
icant differences were detected between the cattle BSE tgBov in-
oculated mice brain profiles and those of mice inoculated with
BSE-DoPrPres or BSE-RaPrPres. However, the striatum (S) of the
animals inoculated with the BSE-DoPrPres showed significantly
less spongiform lesions and PrPd accumulation than the BSE-
RabPrPres or cattle BSE inoculated groups.
The immunolabeling patterns (monoclonal antibody 6H4)
were consistent among the three differently challenged groups of
mice and were mainly extracellular rounded plaque-like deposits
of PrPd. However, other patterns were observed also including
fine punctuate to coarse granular, intraneuronal, perineuronal,
and glial-associated (Fig. 5). The anatomical distribution of the
PrPd deposition intensity was also semiquantitatively assessed
and the profile obtained was considerably similar to that of the
lesions. On the second passage, the brains from BSE-DoPrPres
inoculated tgBov mice showed less PrPd immunolabeling inten-
sity in the cortices and hippocampus than mice from the other
Figure 2. Biochemical analyses of BSE seeded PrP res generated in vitro by saPMCA using
cattle, rabbit, and dog brain homogenates as substrates. Cattle, rabbit, and dog brain homog-
enates seeded with BSE-positive cattle brain homogenate were subjected to saPMCA. Seeded
samples (BSE-BoPrP res, BSE-RaPrP res, and BSE-DoPrP res) from round 10 were digested with
100g/ml PK and analyzed byWestern blot using monoclonal antibody D18. The electropho-
reticmigrationpatterns in all the in vitro samples and the in vivoBSE-positive cattle sampleused
as positive control were indistinguishable. Scrapie was used as reference for determining the
different electrophoretic migration patterns. Control, Undigested cattle brain homogenate.
Table 1. Attack rates andmean survival times (SEM) of inoculated tgBovmice
First passage Second passage
Attack rate
Survival time
(dpi) (SEM) Attack rate
Survival time
(dpi) (SEM)
Cattle BSE 10/10 355 (15) 9/9 348 (11)
BSE-RaPrP res 16/16 395 (16) 11/12a 339 (8)
BSE-DoPrP res 17/17 394 (12) 13/13 274 (9)b
Healthy cattle brain 0/12 500c ND ND
ND, Not determined.
aOne mouse was killed at 365 dpi and was IHC negative and showed no spongiform changes. This animal was not
taken into account for incubation period calculations.
bOne animal was found dead at 96 dpi and was PrP res positive in the brain. This animal was taken out as an outlier
because the cause of death could not be determined due to autolysis.
cAn end point for negative controls was set at 506 dpi, data from other experiments show that healthy brain
homogenate inoculated tgBovmice can survive700 dpi (not shown).
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groups, which could be explained by the shorter incubation pe-
riod (data not shown). Despite this difference in intensity, the
profiles from all groups were similar in shape. The lesion profile
showed a consistently lower PrPd score in the striatum of BSE-
DoPrPres inoculated mice compared with the other two groups.
Preserved ability of rabbit adapted BSE prions to infect a
human transgenic mouse model
Mice carrying the human PRNP gene were also inoculated intra-
cerebrally with the in vitro generated BSE seeded products to
assess their zoonotic potential. The cattle BSE inoculum did not
result in disease in any of the animals (attack rate 0/10), a low
infectivity rate that is consistent with published data on first pas-
sage of BSE in this model (Beringue et al., 2008; Padilla et al.,
2011). Similarly, no animals inoculated with BSE-DoPrPres suc-
cumbed to disease (0/6). However, 2 of 9 mice inoculated with
BSE-RaPrPres died at 560 and 699 dpi showing spongiform le-
sions and PrPd deposits by IHC (Fig. 6; Table 2). The remaining
animals died at different dpi without showing TSE-like signs,
except for those associated to aging, and all were negative in the
three tests performed to confirm TSE diagnosis (spongiform
changes, IHC for PrPd, andWestern blot for PrPres). Spongiform
lesions were minimal in the TSE-positive transgenic mice and
mixed with age-related spongiosis. PrPd deposits were observed
only in the thalamus and consisted of small foci of coarse granular
PrPd aggregates associated with the spongiosis. Overall, these
results show that in vitro rabbit prions, likely enciphering a BSE
strain, preserve the ability to infect humanized mice.
Several mice were found dead because of non-TSE-related
causes but otherwise the animals were kept alive for their recog-
nized lifespan (in the cattle BSE group up to 797 dpi, in the
BSE-RaPrPres group up to 704 dpi, and in the BSE-DoPrPres
group up to 853 dpi).
Discussion
Prion diseases have been known for a long time, especially scrapie
in sheep and goats, and some diseases affecting humans, includ-
ing Kuru and Creutzfeldt-Jakob disease. Yet the occurrence and
identification of the BSE epizootic was a remarkable milestone in
the history of prion disease as cattle had never before been af-
fected by TSE and so were presumed resistant. The recognition
that BSE was zoonotic turned prion diseases of animals into a
serious threat to public health, which resulted in an unprece-
dented crisis of confidence in consumers. Vast amounts ofmoney
were spent in numerous countries, not just to eliminate hundreds
of thousands of infected animals, but also to establish radical
changes related to disease control and surveillance, i.e., diagnos-
tic tests, disposal of specified riskmaterial, which could no longer
be used in the food industry, etc. However, as prion diseases
became the subject of profound scientific study, previously un-
known prion strains have been discovered, many with unknown
species susceptibilities and zoonotic potential. Thus, the suscep-
tibility of different species to prions, particularly those that may
come into close contact with humans, is a matter of continuous
debate and study in the scientific community and great concern
when determining health and safety policies.
Detailed study of naturally occurring prions is not enough to
understand the behavior of these proteins in certain species. Be-
fore 1985, no one could have foreseen the massive cattle BSE
epizootic. Hence, the scientific community is now particularly
cautious when assessing the risk associated with host susceptibil-
ities of various prions. Nevertheless, certain species display a lim-
ited or apparently null susceptibility to prion disease. Therefore,
could one assume that such species would be resistant to all ex-
isting prion strains? If only one prion strain should be able to
infect a new species, it might adapt to the new host and become
easily transmissible. To address this we used all the tools available
(i.e., in vitro amplification and transgenicmousemodels) to eval-
uate the behavior of BSE prions in two historically considered
prion disease resistant species: dogs and rabbits. BSE was chosen
due to its zoonotic properties and because, asmentioned above, it
is a promiscuous strain that has demonstrated infectivity in a
wider range of species thanmost other prions. Even though these
experimental conditions are far frommodeling natural scenarios,
they may enable us to predict the outcome of potential unfore-
seen species susceptibilities and epizootics as occurred with BSE
(mad cow disease). During the last decade, in vitro replication
studies endorsed PMCAas one of themost powerful technologies
to overcome transmission barriers (Castilla et al., 2008; Green et
al., 2008; Ferna´ndez-Borges and Castilla, 2010; Barria et al., 2011;
Kurt et al., 2011; Yoshioka et al., 2011; Chianini et al., 2012).
Figure 3. Survival Curves of cattle BSE, BSE-DoPrP res and Ra-PrP res inoculated tgBovmice. A, First passage; B, second passage. In the survival curves, the vertical axis represents the percentage
of live animals and the horizontal axis the days postinoculation.
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Thus, dog and rabbit normal brain homogenates were seeded
with BSE prions and submitted to in vitro amplification (saP-
MCA) to try to overcome the species transmission barrier. Inter-
estingly, rabbit PrPC could bemisfolded with relative ease by any
of the prion strains used TSE (Barlow and Rennie, 1976;
Ferna´ndez-Borges et al., 2009; Chianini et al., 2012). This was
rather surprising since this species had, until then, been consid-
ered resistant to TSE (Barlow and Rennie, 1976; Ferna´ndez-
Borges et al., 2009; Chianini et al., 2012). However, dog brain
homogenate could not be misfolded until the initial BSE prion
seed concentration was raised considerably, and even with this
modification only BSE was able to misfold dog PrPC, which sug-
gested a strong resistance of this species to BSE.
Comparison of the original cattle BSE prions with those gen-
erated by seeding rabbit and dog brain homogenate with BSE
followed by in vitro saPMCA demonstrated that the biochemical
strain properties of BSE were maintained in the new species, i.e.,
glycoform proportion and molecular weight after PK digestion.
This suggests that the BSE prion’s conformation is reliably trans-
mitted to new PrPC species in vitro. However, to ensure that the
BSE strain’s pathobiological properties was also transmitted, par-
ticularly those regarding infectivity and the ability to cross certain
species barriers, an in vivo approach was mandatory. The trans-
genicmousemodel expressing the bovine PRNP gene was chosen
as it had previously demonstrated to reproduce reliably BSE
strain features. This model was key in determining that BSE ac-
quired a different behavior regarding the length of the incubation
period upon its passage through sheep, while maintaining other
strain features, such as Western blot electrophoretical profile,
molecular weight, and PK resistance (Espinosa et al., 2007). As
Figure 4. Comparative electrophoretic patterns. A, First and second passages of the different samples from tgBovmice (cattle BSE, BSE-DoPrP res, and Ra-PrP res) were compared with natural
cattle BSE. The glycoform ratios and the molecular weights of the PrP res are all indistinguishable from cattle BSE. All samples were digested with 40g/ml PK and analyzed byWestern blot using
monoclonal antibody D18. Cattle BSE and cattle BSE (in tgBov) were loaded several times in the gel for comparative purposes. Three differentmice of each group (A–C) are represented for each type
of sample and passage used. Control, Cattle brain homogenate. B, Triangular plot representing the glycoform proportions evaluated densitometrically from the above gel. Each axis represents the
percentage of each band. H, Biglycosilated; L, monoglycosilated; U, unglycosilated. Notice that all wells show a remarkably similar band proportion.
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predicted by the in vitro experiments (once initially converted,
BSE-DoPrPres andBSE-RaPrPres easily amplified further dog and
rabbit normal brain homogenates in vitro), both rabbit and dog
adapted BSE efficiently infected tgBov mice with attack rates of
100%. Initially the incubation period was slightly longer for both
inocula than that of cattle BSE, probably due to a lack of adapta-
tion of the in vitro generated prions to the new host (bovine)
prion. However, on second passage the incubation periods were
significantly shortened. Interestingly the behavior of BSE-
DoPrPres was similar to that observed in sheep BSE where the
biochemical, lesion, and immunohistochemical features were
unchanged but with a reduction in the incubation period (Espi-
nosa et al., 2007). The neuropathology and molecular signature
of PrPres found in tgBov mice showed no significant differences
between cattle BSE and the two in vitro-generated prions, sug-
gesting that the strain features had not changed upon passage
through rabbit and dog brain homogenates.
The data shown here prove that the difficulties found in mis-
folding certain species of PrPC molecules do not imply a loss of
the pathobiological features encoded in the BSE structure. Com-
paredwith cat PrPC (data not shown), dog PrPwas tremendously
Figure 5. Histopathological characterization of the second passage of cattleBSE, BSE-DoPrP res, and Ra-PrP res in tgBov mice. Lesion profiles and PrP d deposition profiles represent the mean
semiquantitative scoring (0–4, vertical axis) of the spongiform lesions and the immunohistochemical labeling of PrP d deposits, respectively, against 14 brain regions (horizontal axis: Pfc, piriform
cortex; H, hippocampus; Oc, occipital cortex; Tc, temporal cortex; Pc, parietal cortex; Fc, frontal cortex; S, striatum; T, thalamus;M,mesencephalon; P, pons;Mobl,medulla oblongata; Cm, cerebellar
nuclei; Cv, cerebellar vermis; Cc, cerebellar hemispheres). Vertical bars indicate the SD of themean. H&E, Hematoxylin and eosin staining of themesencephalon to evaluate the degree of spongiform
change; PrP d IHC, IHC for PrP d deposits (brown pigment) in the mesencephalon (note the presence of abundant rounded, plake-like PrP d deposits; 6H4 MAb 1:3000). Scale bars, 25m.
Figure 6. Characterization of BSE-RaPrP res inoculated tgHum mice. A, Hematoxylin and
eosin staining showing an area of spongiform change in the thalamus. B, PrP d immunohisto-
chemistry (MAb 6H4) of the same area depicts granular PrP d deposits. Scale bars, 25 m.
Samples were digested with 40g/ml PK and analyzed using monoclonal antibody 6H4.
Table 2. Attack rates and survival times of inoculated tgHummice
First passage
Attack rate Survival times (dpi)
Cattle BSE 0/9 203, 209, 234, 238, 247, 271, 468, 695, 797
BSE-RaPrP res 2/9 170, 219, 306, 327, 371, 496, 560, 699, 705
BSE-DoPrP res 0/6 271, 549, 677, 748, 818, 853
Healthy brain 0/6 370, 428, 463, 625, 692, 693
In bold, the two positive animals’ survival time. The remaining data are survival times in dpi (i.e., days between
inoculation and sacrifice).
7784 • J. Neurosci., May 1, 2013 • 33(18):7778–7786 Vidal et al. • Dog and Rabbit Adapted BSE Infectious Prions
difficult to misfold in vitro. It could only be converted when a
relatively large dose of BSE prion was used as seed. However, the
similarity of dog PrP primary sequence, differing principally in
just three residues (positions: 163, 181, and 189) with cat PrP
(Lysek et al., 2005; Stewart et al., 2012), would predict a similar
behavior to feline spongiform encephalopathy (FSE). In fact, FSE
was one of the first nonbovine prions shown to maintain BSE
strain features (Lezmi et al., 2006). Accordingly, once the bovine–
canine barrier was surpassed, BSE pathobiological features re-
mained stable in BSE-DoPrPres.
However, the results obtained with BSE cannot be used to
predict the behavior of other prion strains when adapted to these
species in vivo or in vitro. Thus, instead of a species transmission
barrier a strain transmission barrier should be considered as sug-
gested by Scott and coworkers (Scott et al., 2005). Prion strains
might be classified according to their ability to transmit to differ-
ent species and also in relation to their adaptability to new hosts
and their permissiveness to change. Therefore, BSE would be a
strain with a low (or null) permissiveness to change and yet high
adaptability to different environments. As such, the zoonotic be-
havior of BSE toward humans can be predicted regardless of the
host infected with the BSE prion. Any species derivation of BSE,
be it rabbit-BSE, dog-BSE, or any other version, is likely to encode
a structure capable of misfolding human PrPC. Second passage
experiments in transgenic mice expressing human PrP (Tg340
mice) would have been useful to determine whether silent infec-
tion was present in mice inoculated with cattle BSE and BSE-
DoPrPres which seems to be a plausible assumption according to
experiments published in this model (Padilla et al., 2011).
Our in vitro and in vivo results predict that, hypothetically, if
BSE infected canids and leporids (considered, so far, prion resis-
tant) it would maintain its pathobiological features; including
zoonotic potential. This is particularly relevant with respect to
rabbit amplified BSE as rabbits are eaten by humans. In conclu-
sion, it is strongly recommended that no mammalian species be
fed with animal protein potentially contaminated with BSE to
prevent a new epizootic and zoonosis of unknown consequences.
Given the difficulties of performing infectivity studies inmany
natural hosts (without previous in vitro replication), transgenic
mice have been generated expressing rabbit and dog PRNP gene
which have been inoculated with cattle BSE, among other strains
of interest, to test the in vivo susceptibility of these PRNP se-
quences. In addition, a detailed study of the primary amino acid
sequences of bovine PrP compared with rabbit and dog PrP,
focusing on the structural peculiarities of each amino acid
change, is ongoing to explain the different PrPC to PrPd conver-
sion abilities of each species.
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